Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POSTCON exenatide postconditioning in STEMI
2007-001221-10Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- Sep 2008
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of exenatide in myocardial infarction (MI) (2 arms), sponsored by Rigshospitalet. Primary endpoints: Infarct size by magnetic resonance imaging, Infarct size by echocardiography and 1 more. Started Sep 2008; status: completed.
02
Drugs
exenatide
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2007-001221-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001221-10.